(Total Views: 105)
Posted On: 08/17/2023 10:00:51 AM
Post# of 36

$PIRS News Article - Pieris Pharmaceuticals Announces Milestone Achievement for Boston Pharmaceuticals' Initiation of Phase 1/2 Study of BOS-342, a 4-1BB/GPC3 Immuno-Oncology Bispecific https://marketwirenews.com/news-releases/pier...09478.html


My Twitter: WhyteStocks